Atlas Trials

Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder

Clinical trial NCT01601210 · COMPLETED

Trial details

NCT number
NCT01601210
Sponsor
Perry Renshaw
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2012-06-01
Primary completion
2014-05-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.